Cargando…

Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors

PURPOSE: This review article is intended to provide a perspective overview of potential strategies to overcome radiation resistance of tumors through the combined use of immune checkpoint and DNA repair inhibitors. METHODS: A literature search was conducted in PubMed using the terms (“DNA repair* an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Classen, Sandra, Petersen, Cordula, Borgmann, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674014/ https://www.ncbi.nlm.nih.gov/pubmed/37420037 http://dx.doi.org/10.1007/s00066-023-02103-8

Ejemplares similares

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
por: Wurster, Stephanie, et al.
Publicado: (2016)

DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients
por: Bold, Ioan T., et al.
Publicado: (2021)

Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
por: Li, Xiaoying, et al.
Publicado: (2021)

Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists
por: Illouz, Frédéric, et al.
Publicado: (2017)

Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer
por: Meyer, Felix, et al.
Publicado: (2020)

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
por: Shi, Congqi, et al.
Publicado: (2022)

Attenuating DNA damage response and immunosuppression radiosensitizes pancreatic cancer
por: Zhang, Yuqing, et al.
Publicado: (2022)

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)

Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
por: Li, Yinuo, et al.
Publicado: (2023)

Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells
por: Hintelmann, Katharina, et al.
Publicado: (2022)

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway
por: Hodson, David, et al.
Publicado: (2023)

Reaction of Electrons with DNA: Radiation Damage to Radiosensitization
por: Kumar, Anil, et al.
Publicado: (2019)

Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?
por: Goff, Peter H., et al.
Publicado: (2021)

The Intra-S Checkpoint Responses to DNA Damage
por: Iyer, Divya Ramalingam, et al.
Publicado: (2017)

Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization Against PARP1 Inhibition in a Replication-Dependent Manner
por: Rieckhoff, Johanna, et al.
Publicado: (2020)

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
por: Deng, Siyao, et al.
Publicado: (2022)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

The DNA damage response pathway regulates the expression of the immune checkpoint CD47
por: Ghantous, Lucy, et al.
Publicado: (2023)

Role of the Checkpoint Clamp in DNA Damage Response
por: Kai, Mihoko
Publicado: (2013)

Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
por: Khononov, Irina, et al.
Publicado: (2021)

GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response
por: Leng, Yang, et al.
Publicado: (2021)

Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast
por: Alao, John-Patrick, et al.
Publicado: (2021)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
por: Cetin, Meryem H., et al.
Publicado: (2023)

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
por: Xie, Deqian, et al.
Publicado: (2023)

DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden
por: Hsiehchen, David, et al.
Publicado: (2020)

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
por: Fang, Jianwen, et al.
Publicado: (2023)

Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance
por: Classen, Sandra, et al.
Publicado: (2022)

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
por: Hintelmann, Katharina, et al.
Publicado: (2021)

DNA damage response and potential biomarkers of radiosensitivity in head and neck cancers: clinical implications
por: Carpov, Domnica, et al.
Publicado: (2023)

Coordinate to Guard: Crosstalk of Phosphorylation, Sumoylation, and Ubiquitylation in DNA Damage Response
por: Kuo, Ching-Ying, et al.
Publicado: (2012)

Epigenetic therapy with inhibitors of histone methylation suppresses DNA damage signaling and increases glioma cell radiosensitivity
por: Gursoy-Yuzugullu, Ozge, et al.
Publicado: (2017)

A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation
por: Fujimori, Hiroaki, et al.
Publicado: (2015)

Indicators of responsiveness to immune checkpoint inhibitors
por: Shields, Bradley D., et al.
Publicado: (2017)

Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response
por: Savarin, Monika, et al.
Publicado: (2017)

Novel “Checkpoint” Mechanism Mediates DNA Damage Responses
Publicado: (2003)

Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
por: Nakamura, Yoshiyuki
Publicado: (2019)

Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
por: Zapata, Luis, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
por: Gubbi, Sriram, et al.
Publicado: (2022)

DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
por: Malaquin, Nicolas, et al.
Publicado: (2015)

Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
por: Kawanishi, Shosuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dkuch30brkvr2dcu8o49mvqb2l